Related Experiment Video

Updated: Feb 27, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.7K

Optimal Therapy of Advanced Stage Mesothelioma

Maria M J Disselhorst1, Sjaak J A Burgers1, Paul Baas2

  • 1Department of Thoracic Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Current Treatment Options in Oncology
|July 7, 2017
PubMed
Abstract

Insights

Optimal treatment for advanced malignant pleural mesothelioma (MPM) remains elusive. Emerging insights into molecular pathways and Immuno-Oncology (IO) combinations offer new therapeutic avenues, potentially personalizing care.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Malignant pleural mesothelioma (MPM) treatment remains a significant challenge.
  • Optimal therapeutic strategies for advanced MPM are not yet established.
  • Advances in understanding molecular pathways are crucial for developing new treatments.

Purpose of the Study:

  • To review current understanding of molecular pathways in MPM.
  • To explore the potential of Immuno-Oncology (IO) combinations for MPM treatment.
  • To discuss the role of personalized medicine in future MPM therapy.

Main Methods:

  • Literature review of recent advancements in MPM research.
  • Analysis of molecular pathways implicated in MPM development and progression.
  • Evaluation of emerging Immuno-Oncology (IO) agents and combination strategies.

Main Results:

  • New therapeutic strategies are emerging due to increased insight into molecular pathways.
  • Combinations of Immuno-Oncology (IO) drugs show promise for advanced MPM.
  • Personalized treatment approaches using cell cultures and pathway analysis are gaining traction.

Conclusions:

  • The optimal treatment for advanced malignant pleural mesothelioma (MPM) is still under investigation.
  • Future MPM treatment is likely to involve a combination of Immuno-Oncology (IO) drugs.
  • Targeted therapies based on specific pathway inhibitors may offer personalized treatment options for MPM patients.
Keywords:
Immuno-oncology drugsMalignant pleural mesotheliomaPathway inhibitorsTherapy

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K